Uncategorized

Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment

Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment

Published

6 days ago

on

As Novo Nordisk cuts 400 jobs at the troubled site, Scholar Rock has seen enough progress that it included the facility in a resubmission for FDA approval.​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version